1. Home
  2. INLX vs VNRX Comparison

INLX vs VNRX Comparison

Compare INLX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • VNRX
  • Stock Information
  • Founded
  • INLX 1996
  • VNRX N/A
  • Country
  • INLX United States
  • VNRX United States
  • Employees
  • INLX N/A
  • VNRX N/A
  • Industry
  • INLX EDP Services
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • INLX Technology
  • VNRX Health Care
  • Exchange
  • INLX Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • INLX 54.2M
  • VNRX 59.6M
  • IPO Year
  • INLX N/A
  • VNRX N/A
  • Fundamental
  • Price
  • INLX $12.88
  • VNRX $0.63
  • Analyst Decision
  • INLX
  • VNRX Strong Buy
  • Analyst Count
  • INLX 0
  • VNRX 4
  • Target Price
  • INLX N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • INLX 3.7K
  • VNRX 154.8K
  • Earning Date
  • INLX 11-13-2024
  • VNRX 11-14-2024
  • Dividend Yield
  • INLX N/A
  • VNRX N/A
  • EPS Growth
  • INLX N/A
  • VNRX N/A
  • EPS
  • INLX N/A
  • VNRX N/A
  • Revenue
  • INLX $17,930,991.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • INLX $8.35
  • VNRX $71,446.31
  • Revenue Next Year
  • INLX $6.48
  • VNRX N/A
  • P/E Ratio
  • INLX N/A
  • VNRX N/A
  • Revenue Growth
  • INLX 7.17
  • VNRX 97.50
  • 52 Week Low
  • INLX $4.99
  • VNRX $0.43
  • 52 Week High
  • INLX $16.50
  • VNRX $1.23
  • Technical
  • Relative Strength Index (RSI)
  • INLX 41.52
  • VNRX 48.89
  • Support Level
  • INLX $12.62
  • VNRX $0.61
  • Resistance Level
  • INLX $13.27
  • VNRX $0.65
  • Average True Range (ATR)
  • INLX 0.62
  • VNRX 0.05
  • MACD
  • INLX -0.11
  • VNRX 0.00
  • Stochastic Oscillator
  • INLX 18.59
  • VNRX 38.10

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: